Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Personalized Immunotherapy in Upper GI Cancers
NCT05153304Phase 2Withdrawn
- Sponsor
- University of California, San Diego
- Start
- Jun 2024
- Primary completion
- Jun 2026
- Modality
- Peptides, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of personalized neoantigen vaccine (UC San Diego) in gastroesophageal adenocarcinoma, gastric adenocarcinoma, sponsored by University of California, San Diego. Planned start Jun 2024; status: withdrawn.
02
Drugs
personalized neoantigen vaccine (UC San Diego)
03
Conditions
gastroesophageal adenocarcinomagastric adenocarcinoma
Beyond the preview
Go deeper on NCT05153304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05153304.